# US 2010/0168356 A1 · Biomedical Devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168356 A1
- Document ID: US20100168356A1
- Status: Published application
- Kind: A1
- Application number: 12/641,464
- Filed: 2009-12-18
- Published: 2010-07-01
- Earliest claimed: 2008-12-30
- Inventors: Yu-Chin Lai; Weihong Lang; David Paul Vanderbilt; Paul L. Valint, JR.; Joseph A. McGee
- Web page: https://patentgrep.com/patent/US20100168356A1

## CPC

- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 2430/16: for reconstruction of eye parts, e.g. intraocular lens, cornea
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Biomedical devices are provided herein which are formed from a polymerization product of a monomeric mixture comprising (a) a polymerizable monomer containing a boronic acid moiety and an electron withdrawing moiety; and (b) a biomedical device-forming comonomer.

## Claims

### Claim 1

A biomedical device which is obtained from a polymerization product of a monomeric mixture comprising (a) a polymerizable monomer containing a boronic acid moiety and an electron withdrawing moiety; and (b) a biomedical device-forming comonomer.

### Claim 2 (depends on 1)

The biomedical device of claim 1, wherein the electron withdrawing moiety is CF3, —NO2, —F, —Cl or Br.

### Claim 3 (depends on 1)

The biomedical device of claim 1, wherein the polymerizable monomer containing a boronic acid moiety and an electron withdrawing moiety comprises a polymerizable ethylenically unsaturated containing aryl boronic acid.

### Claim 4 (depends on 1)

The biomedical device of claim 1, wherein the polymerizable monomer containing a boronic acid moiety comprises a 3-vinylphenylboronic acid or 3-methacrylamidophenylboronic acid.

### Claim 5 (depends on 1)

The biomedical device of claim 1, wherein the biomedical device-forming comonomer is a silicone-containing monomer.

### Claim 6 (depends on 1)

The biomedical device of claim 1, wherein the monomeric mixture further comprises a hydrophilic monomer, hydrophobic monomer or both.

### Claim 7 (depends on 6)

The biomedical device of claim 6, wherein the hydrophilic monomer is selected from the group consisting of an unsaturated carboxylic acid, vinyl lactam, amide, polymerizable amine, vinyl carbonate, vinyl carbamate, oxazolone monomer and mixtures thereof.

### Claim 8 (depends on 6)

The biomedical device of claim 6, wherein the hydrophilic monomer is selected from the group consisting of 2-hydroxyethylmethacrylate, 2-hydroxyethylacrylate, glyceryl methacrylate, N-vinyl pyrrolidone, N-vinyl-N-methyl acetamide, N,N-dimethyl methacrylamide, N,N-dimethylacrylamide, acrylic acid, methacrylic acid and mixtures thereof.

### Claim 9 (depends on 6)

The biomedical device of claim 6, wherein the hydrophobic monomer is selected from the group consisting of a C1-C20 alkyl (meth)acrylate, substituted and unsubstituted C3-C20 cycloalkyl (meth)acrylate, substituted and unsubstituted C6-C30 aryl (meth)acrylates, (meth)acrylonitriles, fluorinated alkyl methacrylates and mixtures thereof.

### Claim 10 (depends on 6)

The biomedical device of claim 6, wherein the hydrophobic monomer is a silicone-containing monomer having from 1 to about 20 silicon atoms.

### Claim 11 (depends on 10)

The biomedical device of claim 10, wherein the silicone monomer is 3-methacryloxypropyl tris(trimethylsiloxy)silane.

### Claim 12 (depends on 6)

The biomedical device of claim 6, wherein the hydrophobic monomer is an aliphatic ring containing monomer selected from the group consisting of isobornyl acrylate, isobornyl methacrylate, cyclohexyl acrylate, cyclohexyl methacrylate and mixtures thereof.

### Claim 13 (depends on 1)

The biomedical device of claim 1, wherein component (a) comprises about 0.1 to about 10 weight percent and the biomedical device-forming comonomer component (b) comprises about 5 to about 90 weight percent, based on the total weight of the mixture.

### Claim 14 (depends on 1)

The biomedical device of claim 1, wherein component (a) comprises about 0.5 to about 2 weight percent and the biomedical device-forming comonomer component (b) comprises about 20 to about 60 weight percent, based on the total weight of the mixture.

### Claim 15 (depends on 1)

The biomedical device of claim 1, which is an ophthalmic lens.

### Claim 16 (depends on 15)

The biomedical device of claim 15, wherein the ophthalmic lens is a contact lens.

### Claim 17 (depends on 16)

The biomedical device of claim 16, wherein the contact lens is a rigid gas permeable lens or a soft contact lens.

### Claim 18 (depends on 1)

The biomedical device of claim 1, which is a silicone hydrogel.

### Claim 19 (depends on 1)

The biomedical device of claim 1, which is an intraocular lens.

### Claim 20 (depends on 1)

The biomedical device of claim 1, which is a corneal implant.
